Agios Pharmaceuticals Inc logo

Agios Pharmaceuticals Inc

1
NAS:AGIO (USA)   Ordinary Shares
$ 48.19 -1.53 (-3.08%) 11:09 PM EST
At Loss
P/B:
3.68
Volume:
351.38K
Avg Vol (2M):
873.28K
Trade In:
Volume:
351.38K
At Loss
Avg Vol (2M):
873.28K

Business Description

Agios Pharmaceuticals Inc logo
Agios Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US00847X1046

Share Class Description:

AGIO: Ordinary Shares
Description
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
Name Current Vs Industry Vs History
Cash-To-Debt 8.75
Equity-to-Asset 0.88
Debt-to-Equity 0.09
Debt-to-EBITDA -0.18
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.05
Distress
Grey
Safe
Beneish M-Score -2.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.08
9-Day RSI 61.57
14-Day RSI 61.48
6-1 Month Momentum % 110.27
12-1 Month Momentum % 71.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.84
Quick Ratio 12.39
Cash Ratio 11.57
Days Inventory 2136.75
Days Sales Outstanding 28.47
Days Payable 1346.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 6.9
Shareholder Yield % 0.47

Financials (Next Earnings Date:2024-08-01)

AGIO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AGIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Agios Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 29.403
EPS (TTM) ($) -6.32
Beta 0.43
Volatility % 54.32
14-Day RSI 61.48
14-Day ATR ($) 1.857415
20-Day SMA ($) 44.931
12-1 Month Momentum % 71.78
52-Week Range ($) 19.795 - 50.35
Shares Outstanding (Mil) 56.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Agios Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Agios Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Agios Pharmaceuticals Inc Frequently Asked Questions

What is Agios Pharmaceuticals Inc(AGIO)'s stock price today?
The current price of AGIO is $48.19. The 52 week high of AGIO is $50.35 and 52 week low is $19.80.
When is next earnings date of Agios Pharmaceuticals Inc(AGIO)?
The next earnings date of Agios Pharmaceuticals Inc(AGIO) is 2024-08-01.
Does Agios Pharmaceuticals Inc(AGIO) pay dividends? If so, how much?
Agios Pharmaceuticals Inc(AGIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1